Takeda Pharmaceutical Co. Ltd. - Debt To Equity Ratio

Takeda Pharmaceutical Co. Ltd.'s Fiscal Year is From April To March.

The item "Debt-To-Equity-Ratio" stands at 0.6515 as of 09/30/2025, the lowest value at least since 06/30/2022, the period currently displayed.

As of the end of Takeda Pharmaceutical Co. Ltd.'s second quarter, the item "Debt To Equity Ratio" stands at 0.6515. This represents a decrease of -0.74 percent compared to it's value at the end of it's first quarter .


Regarding the One-Year-Change of the series, the current value constitutes a decrease of -10.74 percent compared to the value the year prior.
The 1 year change in percent is -10.74.
The 3 year change in percent is -7.67.

The Serie's long term average value is 0.691. It's latest available value, on 09/30/2025, is 5.76 percent lower, compared to it's long term average value.
The Serie's change in percent from it's minimum value, on 09/30/2025, to it's latest available value, on 09/30/2025, is +0.0%.
The Serie's change in percent from it's maximum value, on 03/31/2022, to it's latest available value, on 09/30/2025, is -15.84%.